128 related articles for article (PubMed ID: 5245322)
21. L-Asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia.
Ortega JA; Nesbit ME; Donaldson MH; Hittle RE; Weiner J; Karon M; Hammond D
Cancer Res; 1977 Feb; 37(2):535-40. PubMed ID: 264412
[TBL] [Abstract][Full Text] [Related]
22. [Treatment of childhood acute lymphoblastic leukemia: efficacy of intermittent pulses of 6-mercaptopurine and methotrexate for maintenance chemotherapy, CCLSG-S811 (phase III study). Children's Cancer and Leukemia Study Group].
Koizumi S; Fujimoto T; Takeda T; Yatabe M; Katou K; Kaneko A; Sekine I; Takeshita T; Utsumi J; Kubota H
Rinsho Ketsueki; 1987 Aug; 28(8):1375-84. PubMed ID: 3323563
[No Abstract] [Full Text] [Related]
23. [Results of acute lymphoblastic leukemia treatment in children. (Apropos of 58 cases)].
Goudemand M; Bauters F; Lerche B
Lille Med; 1972 Feb; 17(2):220-7. PubMed ID: 4504533
[No Abstract] [Full Text] [Related]
24. Prophylactic treatment of meningeal leukemia in children by intrathecal methotrexate.
Wahidijat I; Markum AH; Abdulsalam M; Muslichan S; Odang O
Acta Haematol; 1972; 47(2):81-8. PubMed ID: 4623363
[No Abstract] [Full Text] [Related]
25. Maintenance therapy in acute childhood leukemia.
Nagao T; Lampkin BC; Mauer AM
J Pediatr; 1970 Jan; 76(1):134-7. PubMed ID: 5262235
[No Abstract] [Full Text] [Related]
26. [Polychemotherapy of acute leukemia in children (27 cases)].
Hamladji RM; Belkhodja A; Timsit G; Colonna P
Tunis Med; 1968; 46(6):497-501. PubMed ID: 5270904
[No Abstract] [Full Text] [Related]
27. Intrathecal methotrexate.
Rosner F; Lee SL; Kagen M; Morrison AN
Lancet; 1970 Jan; 1(7640):249-50. PubMed ID: 4189061
[No Abstract] [Full Text] [Related]
28. Bone-marrow toxicity of methotrexate: a reassessment.
Douglas ID; Price LA
Br J Haematol; 1973 May; 24(5):625-31. PubMed ID: 4514552
[No Abstract] [Full Text] [Related]
29. [Acute lymphoblastic leukemia: results of treatment in 130 children].
Quintana J; Beresi V; del Pozo H; Schuh W; Del Borgo P; Koporcic M; Arroyo M; Avayú E; Montero T
Rev Chil Pediatr; 1987; 58(3):219-24. PubMed ID: 3483472
[No Abstract] [Full Text] [Related]
30. Recurrent childhood lymphocytic leukemia: clinical and cytokinetic studies of cytosine arabinoside and methotrexate for maintenance of second hematologic remission.
Rivera G; Murphy SB; Aur RJ; Verzosa MS; Dahl GV; Mauer AM
Cancer; 1978 Dec; 42(6):2521-8. PubMed ID: 282003
[No Abstract] [Full Text] [Related]
31. [Acute juvenile lymphatic leukemia in the Netherlands: study ALL II, 1973-5; Foundation Dutch Childhood Leukemia Study Group].
van der Does-van den Berg A; de Koning J; Reerink H; de Vries JA; van Zanen GE
Ned Tijdschr Geneeskd; 1976 Sep; 120(36):1521-8. PubMed ID: 1067480
[No Abstract] [Full Text] [Related]
32. [Active immunotherapy in acute lymphoid leukemia in children. Influence of several factors on the results].
Mathe G; Pouillart P; Schwarzenberg L; Hayat M; Schneider M; Weiner R; Amiel JL; Jasmin G; de Vassal F; Cattan A
Arch Fr Pediatr; 1973 Jan; 30(1):65-81. PubMed ID: 4516058
[No Abstract] [Full Text] [Related]
33. [Intensive chemotherapy of acute lymphoblastic leukemia in childhood: evaluation of our experience].
Tontoli N; Correra A; Saviano P; Vetrella A; De Masi RV; Florino G; Lagonigro F
Pediatria (Napoli); 1981 Dec; 89(4):805-13. PubMed ID: 6955759
[No Abstract] [Full Text] [Related]
34. Formal discussion: the clinical pharmacology of anti-leukemia agents.
Holland JF
Cancer Res; 1965 Oct; 25(9):1639-41. PubMed ID: 5295365
[No Abstract] [Full Text] [Related]
35. Complication of methotrexate-maintained remission in lymphoblastic leukemia.
Rawbone RG; Shaw MT; Jackson JG; Bagshawe KD
Br Med J; 1971 Nov; 4(5785):467-8. PubMed ID: 5315979
[No Abstract] [Full Text] [Related]
36. Intermittent therapy with 6-mercaptopurine (NSC-755) and methotrexate (NSC-740) given intravenously to adults with acute leukemia.
Ellison RR; Hoogstraten B; Holland JF; Levy RN; Lee SL; Silver RT; Leone LA; Cooper T; Oberfield RA; Ten Pas A; Blom J; Jacquillat C; Haurani F
Cancer Chemother Rep; 1972 Aug; 56(4):535-42. PubMed ID: 4507688
[No Abstract] [Full Text] [Related]
37. Remission induction of meningeal leukemia with high-dose intravenous methotrexate.
Balis FM; Savitch JL; Bleyer WA; Reaman GH; Poplack DG
J Clin Oncol; 1985 Apr; 3(4):485-9. PubMed ID: 3856631
[TBL] [Abstract][Full Text] [Related]
38. Comparison of methotrexate with 6-mercaptopurine-prednisone in treatment of acute leukemia in adults.
Vogler WR; Huguley CM; Rundles RW
Cancer; 1967 Aug; 20(8):1221-6. PubMed ID: 5230457
[No Abstract] [Full Text] [Related]
39. Encephalopathy in acute leukaemia associated with methotrexate therapy.
Kay HE; Knapton PJ; O'Sullivan JP; Wells DG; Harris RF; Innes EM; Stuart J; Schwartz FC; Thompson EN
Arch Dis Child; 1972 Jun; 47(253):344-54. PubMed ID: 4504035
[TBL] [Abstract][Full Text] [Related]
40. Methotrexate/L-asparaginase combination chemotherapy for patients with acute leukemia in relapse: a study of 36 children.
Harris RE; McCallister JA; Provisor DS; Weetman RM; Baehner RL
Cancer; 1980 Nov; 46(9):2004-8. PubMed ID: 6968621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
